Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi agents for inhibiting expression of receptor for advanced glycation end-products, compositions thereof, and methods of use

RNAi agents for inhibiting expression of receptor for advanced glycation end-products, compositions thereof, and methods of use

US Patent 12486502 · Granted Dec 2, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo2025
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo2025
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025
Alpha-v beta-6 integrin ligands and uses thereof2024
Alpha-v beta-6 integrin ligands and uses thereof2024
RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions the2024
RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions the2024
RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), composit2024
RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods2023
RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods2023